NCT00020709View on ClinicalTrials.gov

Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

840

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

February 28, 2007

Conditions
Adenocarcinoma of the LungBronchoalveolar Cell Lung CancerLarge Cell Lung CancerSquamous Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Interventions
DRUG

cisplatin

Given IV

DRUG

docetaxel

Given IV

DRUG

etoposide

Given IV

DRUG

gefitinib

Given orally

RADIATION

radiation therapy

Undergo radiation therapy

OTHER

placebo

Given orally

Trial Locations (1)

78245

Southwest Oncology Group (SWOG) Research Base, San Antonio

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00020709 - Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter